← Eichor
Study identifier: NCT06485934 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Kinesiophobia Scale for the Upper Extremity

Condition: Shoulder Injuries  ·  Sponsor: Emre Şenocak

PhaseN/A
Planned participants150
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Questionnaires/scales used to evaluate kinesiophobia in the literature are limited and are not specific to the upper extremity in existing scales. For this reason, the primary purpose and subject of the study is to develop a multi-factor kinesiophobia scale specific to shoulder problems. The study is an observational research. Participants will be interviewed twice in total. All primary and secondary outcomes will be assessed at the first meeting. The second come will be performed within 5-7 days after the first assessment. In the second come, only the new kinesiophobia scale that is intended to be developed will be applied.

This description comes directly from the study's public registry record.

Talk to the study team

Emre Şenocak, PhD  ·  +90 553 569 56 92  ·  emre.senocak@windowslive.com

Aysel Yıldız Özer, Professor  ·  +90 533 467 44 33  ·  aysel.yildiz@marmara.edu.tr

Always discuss trial participation with your own doctor first.

Locations (2)

Clinic of İstanbul Hand-Microsurgery RehabilitationIstanbul, Turkey (Türkiye)Not Yet Recruiting
Clinic of İstanbul Hand-Microsurgery RehabilitationIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06485934